Curanex Pharmaceuticals Inc Common Stock (CURX) — Financial Flexibility Index
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Financial Flexibility Index of -49.40x as of September 2025. Free cash flow of $-9.19 Million (operating CF $-9.19 Million minus capex $0.00) represents -49% of total liabilities ($185.96K). Also explore net asset growth rate of Curanex Pharmaceuticals Inc Common Stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for Curanex Pharmaceuticals Inc Common Stock across 2 annual periods. See Curanex Pharmaceuticals Inc Common Stock (CURX) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Curanex Pharmaceuticals Inc Common Stock (2023–2024)
Year-by-year free cash flow to debt coverage for Curanex Pharmaceuticals Inc Common Stock. For the full company profile including market capitalisation, see CURX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -38.12x | $-555.57K | $-555.58K | $14.57K | ▼ -453377.3% |
| 2023 | -0.01x | $-120.00 | $-120.00 | $14.28K | — |